BioGX announced the launch of a point-of-care (POC) CE-Marked, three gene multiplex COVID-19 test on its pixl platform.
Tag: Point Of Care Diagnostics
EVIK Dx Innovations is Expanding
EVIK is expanding personnel and equipment capacity of both R & D and production. We are adding to our expertise of reagent formulation to continue to improve our Lyophilization success.
GattaCo and GenScript Announce Co-Marketing and Distribution Agreement for Self-Plasma Collection Device
Contact: Pankaj Singhal
Email: [email protected]
Website: www.gattaco.com
GattaCo Booth #5043
GenScript Booth #3253
Vicki Noble, MD, appointed Chair of Department of Emergency Medicine at UH Cleveland Medical Center, and Emergency Medicine Physician-in-Chief for system
Vicki Noble, MD, has been named Chair, Department of Emergency Medicine at University Hospitals Cleveland Medical Center, and Emergency Medicine Physician-in-Chief for the UH health system.
RADx diversifies COVID-19 test portfolio with four new contracts, including one to detect variants
NIH has awarded four additional contracts for the development and scaled-up manufacturing of new COVID-19 diagnostic testing technologies through its Rapid Acceleration of Diagnostics Tech (RADx) initiative. The awards total $29.3 million and will help increase testing capacity for COVID-19.
Rutgers Researchers Awarded $20 Million NIH Grant to Find New Ways to Diagnose Tuberculosis
Rutgers researchers have been awarded a $20 million grant by the National Institutes of Health (NIH) to evaluate new point of care tests that would diagnose Tuberculosis, the number one cause of deaths worldwide due to an infectious disease.
NUS research team develops portable COVID-19 diagnostic system for rapid on-site testing
A team of researchers from the National University of Singapore has developed a portable COVID-19 micro-PCR diagnostic system, Epidax, that enables accurate on-site screening to be completed in about one hour.
RADx Tech: Diagnosing Disease-Delivering Health
Learn how NIH’s new Rapid Acceleration of Diagnostics initiative, or RADx Tech, has mobilized engineers and innovators across the country to bring accurate, rapid, and easy-to-use COVID diagnostic tests to all Americans.
Briefing: Point-of-Care Testing—Bringing the Lab to the Patient
Point-of-care testing is transforming healthcare: this type of testing helps patients get diagnosed and treated faster, and also makes it easier for patients in remote areas to have access to medical testing. Join AACC and leading experts in laboratory medicine for a discussion about what lies ahead for point-of-care testing and what needs to happen so that all patients can benefit from quality testing of this kind.
PixCell’s Viscoelastic Focusing Technology Shifts the Paradigm in Hematology Point of Care Accessibility
Pixcell’s HemoScreen™ is a portable cartridge-based platform. It is fast, simple to use, and a cost-effective means of providing crucial diagnostic information, near patient, where it is needed most.